(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
CAS: 53101-49-8
Ref. 3D-DCA10149
| 1g | 1,189.00 € | ||
| 50mg | 207.00 € | ||
| 100mg | 330.00 € | ||
| 250mg | 517.00 € | ||
| 500mg | 797.00 € |
Product Information
- (2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid
(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (HMCA) is a supplement that is used to treat cancer. HMCA is an acetyl donor and can be used as a substitute for erythromycin. HMCA was shown to inhibit the growth of human breast cancer cells in culture by reacting with lorazepam and lipase to form a reactive intermediate. This compound has been immobilized on ion-exchange resin for use in biodegradable materials and can be used for the treatment of chronic obstructive pulmonary disease (COPD).
Chemical properties
Technical inquiry about: 3D-DCA10149 (R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
